Total Value in 2020: $31.06M (93 deals)

Deal title Principal company/nonprofit Partner company/nonprofit Value (US$M) Start date

February

Advent to manufacture Jenner Institute's ChAdOx1 nCoV-19 vaccine against coronavirus infection Advent Srl The Jenner Institute Payment unspecified 2/10/20
Sapphire Biotech and ASU to conduct preclinical studies using quiescin sulfhydryl oxidase 1 as anti-neoplastic compounds Arizona State University Sapphire Biotech Inc. Payment unspecified 2/10/20
Biomarin and ARUP laboratories to develop companion diagnostic for valoctocogene roxaparvovec in hemophilia A patients ARUP Laboratories Biomarin Pharmaceutical Inc. Payment unspecified 2/20/20
VUMC to use Berkeley's Beacon optofluidic platform to screen blood samples for antibodies discovery against coronavirus (COVID-19) in the US Berkeley Lights Inc. Vanderbilt University Medical Center Payment unspecified 2/28/20
University of Queensland to use Berkeley's Beacon optofluidic platform to expedite development of recombinant subunit vaccine program for coronavirus (COVID-19) in Australia Berkeley Lights Inc. University of Queensland Payment unspecified 2/28/20
Children's Memorial Health Institute to conduct phase I clinical trial of CNS Pharma's Berubicin against pediatric brain cancer in Poland Children's Memorial Health Institute, Poland CNS Pharmaceuticals Inc. Payment unspecified 2/11/20
Chugai to supply cancer drugs to National Cancer Center Japan for patient-requested therapy system Chugai Pharmaceutical Co. Ltd. Japanese National Cancer Center Payment unspecified 2/7/20
Dyadic and IIBR expanded their collaboration to combat the COVID-19 virus outbreak with vaccines and monoclonal antibodies developed using C1 gene expression platform Dyadic International Inc. Israel Institute for Biological Research Payment unspecified 2/25/20
University of Rochester and Evgen to advance SFX-01 into a clinical trial against chronic kidney disease Evgen Pharma plc University of Rochester Payment unspecified 2/13/20
Fudan University to screen Coronavirus related pneumonia patients using Active Motif's single-cell Abepic technology Fudan University Active Motif LLC Payment unspecified 2/26/20
Biology Institute of Shandong Academy of Sciences to award a contract to Generex for the development of a COVID-19 vaccine Generex Biotechnology Corp. Biology Institute of Shandong Academy of Sciences $6.00 2/27/20
German Red Cross to supply Erytech's donor red blood cells to manufacture eryaspase in Europe German Red Cross Blood Donor Service Erytech Pharma SA Payment unspecified 2/20/20
Oncologie and Moffitt Cancer Center to study tumor microenvironment for precision medicine against gastric and gastrointestinal cancers H Lee Moffitt Cancer Center and Research Institute Oncologie Inc. Payment unspecified 2/25/20
Venturis to use JCU's intellectual property rights related to peptide-based technology to develop wound healing approaches James Cook University of North Queensland Venturis Therapeutics Inc. Payment unspecified 2/25/20
BARDA and Janssen to develop coronavirus vaccine against COVID-19 coronavirus Johnson & Johnson U.S. Department of Health and Human Services Payment unspecified 2/11/20
Cocrystal to use intellectual property rights related to KSURF's antiviral compounds for the treatment of norovirus and coronavirus infections Kansas State University Research Foundation Cocrystal Pharma Inc. $3.20 2/12/20
Bridge Biotherapeutics acquires Konkuk University's drug development candidate for back-eye disorder treatments Konkuk University Bridge Biotherapeutics Inc. $8.53 2/5/20
LDC and Leibniz Institute to develop GRK-5 Inhibitors for the treatment of heart failure and cardiac hypertrophy Leibniz - Institut Für Analytische Wissenschaften - Isas - Ev Lead Discovery Center GmbH Payment unspecified 2/5/20
Theratechnologies and Massachusetts General Hospital for the development of tesamorelin against nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in people living with HIV Massachusetts General Hospital Theratechnologies Inc. Payment unspecified 2/4/20
MD Anderson Cancer to conduct research on Berg's ubiquitin-conjugating enzyme modulators against solid tumor and pancreatic cancer MD Anderson Cancer Center Berg Pharma LLC Payment unspecified 2/27/20
INIA and AB-Biotics to develop and commercialize probiotic strains as antimicrobials worldwide National Institute of Agricultural and Food Technology and Research (INIA) AB Biotics Payment unspecified 2/10/20
NIAID to evaluate the safety and efficacy of the Gilead's remdesivir in hospitalized adults diagnosed with COVID-19 National Institute of Allergy and Infectious Diseases Gilead Sciences Inc. Payment unspecified 2/25/20
Innovation to enter material transfer agreement with NIAID's RBLs to evaluate brilacidin against coronavirus infection National Institute of Allergy and Infectious Diseases Innovation Pharmaceuticals Inc. Payment unspecified 2/27/20
Medigen Biotechnology and NIH to develop COVID-19 vaccine National Institutes of Health Medigen Biotechnology Corp. Payment unspecified 2/16/20
Novartis and DNDi to develop oral LXE-408 for visceral leishmaniasis Novartis AG Drugs for Neglected Diseases Initiative Payment unspecified 2/25/20
Orgenesis to provide point-of-care platform for John Hopkins University to develop and supply cell and gene based clinical therapeutics Orgenesis Inc. Johns Hopkins University Payment unspecified 2/19/20
Toa Eiyo to develop Osaka University's CNT-01 against triglyceride deposit cardiomyovasculopathy worldwide Osaka University Toa Eiyo KK Payment unspecified 2/17/20
Perelman School to advance the development of Active Biotech's tasquinimod for multiple myeloma Perelman School of Medicine Active Biotech AB Payment unspecified 2/5/20
PCOM and Organic Remedies to study medical marijuana for therapeutic applications, including chronic pain and opioid management Philadelphia College of Osteopathic Medicine Organic Remedies Payment unspecified 2/24/20
Gibson Oncology to commercialize Purdue University's azaindenoisoquinolines against cancer worldwide Purdue University Gibson Oncology LLC Payment unspecified 2/10/20
RFU and Exicure to develop therapeutics for genetic diseases Rosalind Franklin University of Medicine & Science Exicure Inc. Payment unspecified 2/13/20
BARDA and Sanofi to develop coronavirus vaccine candidate using recombinant DNA platform for Coronavirus infection Sanofi Pasteur Inc. U.S. Department of Health and Human Services Payment unspecified 2/18/20
Enochian Biosciences acquires hepatitis B virus therapy from Seraph Research Institute Seraph Research Institute Enochian Biosciences Inc. Payment unspecified 2/2/20
Shanghai Ruijin to conduct clinical study of Cellular Biomedicine's mesenchymal stem cell exosomes for novel coronavirus pneumonia Shanghai Ruijin Hospital Cellular Biomedicine Group Inc. Payment unspecified 2/28/20
SERI and Gemini to identify targets using precision medicine GEM-103 for dry age-related macular degeneration and other ocular disorders Singapore Eye Research Institute Gemini Therapeutics Payment unspecified 2/26/20
Southern Research to test Tonix's TNX-1800 for COVID-19 infection Southern Research Institute Tonix Pharmaceuticals Inc. Payment unspecified 2/26/20
Spaulding Clinical Research to conduct clinical trials for FDA's drugs for prolongation of QT Spaulding Clinical Food and Drug Administration $5.00 2/27/20
Cystic Fibrosis Foundation to support the development of Synspira Therapeutics' SNSP-003 to treat malabsorption syndromes Synspira Therapeutics Inc. Cystic Fibrosis Foundation Payment unspecified 2/12/20
Beroni and Tianjin University to develop a medical solution for the Covid-19 infection Tianjin University Beroni Group Ltd. Payment unspecified 2/20/20
TMDU and ACT Genomics to evaluate genomic profiles in Japanese cancer patients Tokyo Medical and Dental University ACT Genomics Co. Ltd. Payment unspecified 2/12/20
NIH and Tuskegee University to develop immunotherapy approaches for cancers and other diseases Tuskegee University National Institutes of Health Payment unspecified 2/27/20
Sanofi Pasteur and HHS to advance COVID-19 vaccine U.S. Department of Health and Human Services Sanofi Pasteur Inc. Payment unspecified 2/18/20
University of Campinas and Entourage to identify and develop therapeutic candidates from 240 cannabis varieties for refractory epilepsy Universidade Estadual de Campina Entourage Phytolab Payment unspecified 2/3/20
University of Alaska Fairbanks to grant rights of drug composition patent to Be Cool Pharmaceutics for inducing hibernation state University of Alaska Fairbanks Be Cool Pharmaceutics LLC Payment unspecified 2/3/20
UCI and Agex to develop and commercialize cell therapies using Purestem technology for neurological disorders University of California Irvine Agex Therapeutics Inc. Payment unspecified 2/3/20
Benevolentai and University of California to discover and develop non-invasive therapeutic treatments for cerebral cavernous malformations University of California San Diego Benevolentai Ltd. Payment unspecified 2/12/20
Genprex to use University of Pittsburgh's gene therapy candidate for the treatment of type 1 and type 2 diabetes University of Pittsburgh Genprex Inc. Payment unspecified 2/11/20
GSK and University of Queensland to develop 2019-nCoV vaccine using pandemic vaccine adjuvant platform technology University of Queensland Glaxosmithkline plc Payment unspecified 2/3/20
NCI to enter a CRADA with VBL Therapeutics to evaluate VB-111 in combination in phase II study with nivolumab in patients with metastatic colorectal cancer VBL Therapeutics National Cancer Institute Payment unspecified 2/20/20
WPD Pharmaceuticals to use Wake Forest University's intellectual property rights related to WPD-101, WPD-102 and WPD-103 for glioblastoma and other tumors Wake Forest University WPD Pharmaceuticals Inc. Payment unspecified 2/24/20
Dianomi Therapeutics licensed a second suite of intellectual property from the Wisconsin Alumni Research Foundation to expand use of mineral-coated microparticle technology into nucleic acid therapy Wisconsin Alumni Research Foundation Dianomi Therapeutics Inc. Payment unspecified 2/11/20

No Comments